Gideon Spanier
Jun 29, 2020

Sanofi puts agencies on alert in global media pitch

Pharmaceuticals giant spends estimated €900m a year.

Dioralyte: Sanofi brand
Dioralyte: Sanofi brand

Sanofi, the French pharmaceuticals giant that is involved in the search for a coronavirus vaccine, has kicked off a global media agency review despite the pandemic.

Havas is the incumbent in North America and WPP’s Mindshare manages the business in most of the rest of the world.

Industry sources say Sanofi has contacted major agency holding companies about the review, although the company did not respond to a request for comment.

MediaSense is understood to be advising on the pitch but would not comment.

Campaign previously reported that Sanofi spent an estimated €900m (£820m) on media at the time of its last media review in 2017.

Sanofi brands include stomach medicine Buscopan, diarrhoea treatment Dioralyte and allergy eye-drop Opticrom.

The company said it had 6.6% revenue growth in the first quarter of 2020 and is "well-positioned to navigate" the pandemic, given demand from the health sector, including the development of "vaccine candidates and therapeutics" to combat Covid-19.

'Underappreciation for digital marketing'

Paul Hudson, the British-born chief executive of Sanofi, has been in charge since September 2019, after joining from Novartis, and has a background in sales and marketing roles at GlaxoSmithKline and Sanofi Synthelabo UK.

Hudson indicated during Sanofi’s most recent earnings call that the company plans to step up investment in online marketing and do less face-to-face communication in the wake of the coronavirus outbreak.

"There was always an underappreciation for digital marketing," Hudson said, noting that both doctors and pharma companies were used to face-to-face meetings in person.

There is now an "appetite for healthcare professionals to get information digitally", although he expects a mix of digital and face to face – "what we call high touch and high tech" – in a post-virus world.

That should allow Sanofi "to be more efficient, to lower the overall cost to serve a healthcare professional or to broaden our reach at the same cost", Hudson explained.

About 20,000 people, or more than 20% of Sanofi’s staff, work in marketing and other support functions.

Before the 2017 review, Publicis Media’s Zenith handled the majority of Sanofi’s media planning and buying. 

Source:
Campaign UK

Related Articles

Just Published

22 hours ago

Alibaba posts slowest quarterly growth on record, ...

Losses increased because of decline in value of investments in publicly-traded companies; backing for newer businesses such as Taocaicai and Taobao Deals; and the continued impact of Covid.

23 hours ago

Tech Bites: Week of May 23, 2022

News from Yahoo, JCDecaux, CREA, PubMatic, Xaxis and more. Plus, Alibaba reaches a milestone in the quarter of serving over 1 billion annual active consumers in China

1 day ago

Heineken sends RFI to creative agencies

The global brewer is looking to kick off meetings in Cannes in pursuit of a new global creative ecosystem.

1 day ago

Should luxury brands reduce their dependence on China?

For luxury brands, taking the current Covid-impacted softness in mainland China as a cue to reduce exposure to the market is the wrong approach.